White House ‘naloxone summit’ omitting prominent advocates for lower costs
To combat the opioid crisis, the White House is convening naloxone makers, but leaving out some of their loudest critics.
The invite list for the White House’s upcoming “summit” on naloxone pricing and accessibility has some noteworthy omissions.
Two of the most prominent organizations focused on providing cheaper overdose-reversal medications will be conspicuously absent from Tuesday’s event: Harm Reduction Therapeutics, a nonprofit drug manufacturer currently seeking approval for a naloxone nasal spray, and Remedy Alliance, a group that distributes cheap naloxone to harm-reduction groups across the country.
What's Your Reaction?
